Literature DB >> 26668520

Coexistence of hepatoma with mantle cell lymphoma in a hepatitis B carrier.

Mu-Hsien Lee1, Yu-Ching Lin1, Hao-Tsai Cheng1, Wen-Yu Chuang1, Hsin-Chih Huang1, Hsiao-Wen Kao1.   

Abstract

The coexistence of hepatocellular carcinoma (HCC) and non-Hodgkin's lymphoma (NHL) in the liver is rare. Reports show that these patients have cirrhotic livers or hepatitis virus infections before they develop HCC and NHL. We present a patient with hepatitis B virus infection who was transferred to our hospital with a newly detected liver mass; abdominal computed tomography examination showed one hypodense mass of 7 cm in diameter and multiple mesenteric and mediastinal lymph nodes. A liver tumor biopsy showed a hepatoma, and the pathologic findings from an inguinal lymph node excision showed mantle cell lymphoma. An immunohistochemical stain confirmed that the atypical lymphoid cells within the HCC were positive for the CD20, CD5 and cyclin D1 antigens. Taking these findings into account, the hepatic tumor was determined to be a HCC infiltrated by mantle cell lymphoma.

Entities:  

Keywords:  Hepatitis B virus; Hepatocellular carcinoma; Mantle cell lymphoma

Mesh:

Substances:

Year:  2015        PMID: 26668520      PMCID: PMC4671051          DOI: 10.3748/wjg.v21.i45.12981

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Simultaneous occurrence of hepatocellular carcinoma and low grade non-Hodgkin's lymphoma in a chronic hepatitis B surface antigen carrier.

Authors:  R Monarca; M Montanaro; T Stroffolini
Journal:  Ann Hematol       Date:  1999-11       Impact factor: 3.673

Review 2.  Hepatocellular carcinoma--epidemiological trends and risk factors.

Authors:  Kerstin Schütte; Jan Bornschein; Peter Malfertheiner
Journal:  Dig Dis       Date:  2009-06-22       Impact factor: 2.404

3.  Hepatocellular carcinoma infiltrated with non-Hodgkin's lymphoma: report of a case.

Authors:  Tohru Utsunomiya; Masahiro Okamoto; Eiji Tsujita; Manabu Yamamoto; Shinichi Tsutsui; Megumu Fujihara; Teruyoshi Ishida
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

4.  Simultaneous occurrence of a hepatocellular carcinoma and a hepatic non-Hodgkin's lymphoma infiltration.

Authors:  Sabine Heidecke; Dirk L Stippel; Arnulf H Hoelscher; Inga Wedemeyer; Hans-Peter Dienes; Uta Drebber
Journal:  World J Hepatol       Date:  2010-06-27

5.  Association of non-Hodgkin's lymphoma and hepatocellular carcinoma.

Authors:  M Di Stasi; L Cavanna; F Fornari; G Civardi; S Rossi; G Sbolli; M Giacani; S Fermi; L Buscarini
Journal:  Oncology       Date:  1990       Impact factor: 2.935

Review 6.  Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities.

Authors:  Fabrizio Marcucci; Alfonso Mele
Journal:  Blood       Date:  2010-10-19       Impact factor: 22.113

7.  Simultaneous relapse of liver cell carcinoma and non-Hodgkin's lymphoma in the liver. Report of a case with diagnosis by ultrasonically guided fine needle aspiration biopsy.

Authors:  L Cavanna; G Civardi; F Fornari; D Vallisa; R Berte; E Buscarini; G Sbolli; C Paties; R Foroni; M Di Stasi
Journal:  Acta Cytol       Date:  1994 May-Jun       Impact factor: 2.319

8.  Hepatitis C infection and risk of malignant lymphoma.

Authors:  Claudia Schöllkopf; Karin Ekström Smedby; Henrik Hjalgrim; Klaus Rostgaard; Inge Panum; Lasse Vinner; Ellen T Chang; Bengt Glimelius; Anna Porwit; Christer Sundström; Mads Hansen; Hans-Olov Adami; Mads Melbye
Journal:  Int J Cancer       Date:  2008-04-15       Impact factor: 7.396

9.  Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma.

Authors:  Xing-Dong Xiong; Fu-En Qiu; Jian-Hong Fang; Yi Shen; Chun Liang; Wenqi Jiang; Shi-Mei Zhuang
Journal:  Mutat Res       Date:  2008-12-03       Impact factor: 2.433

10.  Hepatic mucosa-associated lymphoid tissue lymphoma and hepatocellular carcinoma in a patient with hepatitis B virus infection.

Authors:  Fuminao Takeshima; Masaki Kunisaki; Tomoyuki Aritomi; Masayuki Osabe; Fumitaka Akama; Tomonori Nakasone; Daisuke Niino; Sayaka Katayama; Hajime Isomoto; Katsuhisa Omagari; Yohei Mizuta; Ikuo Murata; Shigeru Kohno
Journal:  J Clin Gastroenterol       Date:  2004-10       Impact factor: 3.062

View more
  2 in total

1.  Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.

Authors:  Qijun Li; Yong Dong; Yubin Pan; Honglin Tang; Da Li
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

Review 2.  Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases.

Authors:  Youxi Yu; Xiaoju Shi; Xingtong Wang; Ping Zhang; Ou Bai; Yan Li
Journal:  Cell Biosci       Date:  2022-03-12       Impact factor: 7.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.